Genetic Testing in Breast Cancer: The Rules Are Changing

September 6, 2019

(Medscape) – The cost of genetic and genomic testing has plummeted in recent years, and as a result, physicians now face new challenges both in recommending testing and interpreting the results. Oncologist and epidemiologist Allison Kurian, MD, MSc, has dedicated her career to these issues at Stanford, where she directs the Women’s Clinical Cancer Genetics Program. Medscape contributor Lidia Schapira spoke to Kurian about this new era of more affordable and accessible genetic testing, particularly about when to test and how to interpret clinically challenging results for patients and families.

Recommended Reading